There were 526 press releases posted in the last 24 hours and 194,136 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Tellus Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for Neonatal Brain Injury Program TT-20

TO:
Jason Kralic
Tellus Therapeutics, Inc.
+1 919-491-4995

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image